Astonea Labs Ltd
Astonea Labs Ltd (ASTONEALAB) last reported results for the quarter ended Mar 2026, with sales of ₹81 crore and net profit of ₹3 crore. The stock last traded at ₹335, a market capitalisation of ₹352 crore, on a P/E of 77.9. Over the past 52 weeks the stock has ranged between ₹118 and ₹369. Figures are as of 6 Oct 2026 and are not real time.
Astonea Labs Ltd share price and key metrics
- Current price
- ₹335
- Market cap
- ₹352 cr
- Stock P/E
- 77.9
- Book value
- ₹54.4
- ROE
- 12.0%
- ROCE
- 10.5%
- Dividend yield
- 0.00%
- 52w high / low
- 369/118
Metrics as of 6 Oct 2026. Not real time.
Track Astonea Labs Ltd
Cruxal reads every Astonea Labs Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Astonea Labs Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 30%
- TTM
- 51%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 97%
- TTM
- -16%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- 107%
- 10 Years
- %
- 5 Years
- 19%
- 3 Years
- 22%
- Last Year
- 12%
Astonea Labs Ltd quarterly results
| ₹ crore | Sep 2024 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 47 | 66 | 81 |
| Expenses | 41 | 61 | 73 |
| Operating profit | 7 | 5 | 8 |
| OPM % | 14% | 8% | 10% |
| Other income | 0 | 0 | 0 |
| Interest | 2 | 2 | 2 |
| Depreciation | 2 | 2 | 3 |
| Profit before tax | 3 | 2 | 4 |
| Tax % | 24% | 20% | 20% |
| Net profit | 2 | 1 | 3 |
| EPS (₹) | 2.76 | 1.35 | 2.95 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Astonea Labs Ltd annual results
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 30 | 67 | 80 | 98 | 148 |
| Operating profit | 6 | 7 | 12 | 15 | 14 |
| OPM % | 19% | 11% | 15% | 16% | 9% |
| Net profit | 0 | 1 | 4 | 5 | 5 |
| EPS (₹) | 0.62 | 1.68 | 5.36 | 6.93 | 4.30 |
TTM is the trailing twelve months to the most recent quarter.
Astonea Labs Ltd balance sheet
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 4 | 4 | 8 | 8 | 11 |
| Reserves | 3 | 4 | 4 | 11 | 47 |
| Borrowings | 30 | 36 | 42 | 53 | 43 |
| Other liabilities | 16 | 20 | 26 | 32 | 46 |
| Total liabilities | 53 | 64 | 81 | 103 | 146 |
| Fixed assets | 21 | 21 | 22 | 26 | 31 |
| CWIP | 0 | 0 | 2 | 4 | 8 |
| Investments | 0 | 0 | 0 | 0 | 6 |
| Other assets | 32 | 44 | 57 | 73 | 101 |
| Total assets | 53 | 64 | 81 | 103 | 146 |
As reported by the company. Total assets equal total liabilities by construction.
Astonea Labs Ltd cash flow
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operations | -5 | -1 | 8 | 9 | -14 |
| Cash from investing | -3 | -3 | -8 | -11 | -20 |
| Cash from financing | 8 | 4 | -0 | 2 | 34 |
| Net cash flow | -0 | 0 | -1 | -0 | 0 |
| Free cash flow | -8 | -4 | 0 | -2 | -28 |
| CFO / operating profit | -75% | -9% | 71% | 70% | -88% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Astonea Labs Ltd operating ratios
| Per year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | — | 8% | 17% | 17% | 11% |
| Debtor days | 235 | 104 | 116 | 142 | 129 |
| Inventory days | 136 | 121 | 161 | 161 | 125 |
| Days payable | 273 | 128 | 149 | 144 | 150 |
| Cash conversion cycle | 98 | 97 | 128 | 159 | 103 |
| Working capital days | 98 | 33 | 28 | 22 | 74 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Astonea Labs Ltd shareholding pattern
Promoters held 72.30% at Mar 2026, broadly unchanged since Jun 2025. FIIs 0.00% and DIIs 0.07%.
| % held | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Promoters | 72.30% | 72.30% | 72.30% |
| FIIs | 8.01% | 2.51% | 0.00% |
| DIIs | 4.55% | 0.35% | 0.07% |
| Public | 15.15% | 24.84% | 27.62% |
| No. of shareholders | 1,014 | 437 | 376 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Astonea Labs Ltd corporate filings
- Astonea Labs Ltd updates CIN following alteration of Object Clause in MOACompany Updatelow impact
Cruxal's analysis: Astonea Labs Ltd has announced a change in its Corporate Identification Number (CIN) due…
Read the full analysis - Astonea Labs Ltd incorporates a new subsidiary, Longevity Science Private Limited, as per SEBI Regulation 30 filingCompany Updatelow impact
Cruxal's analysis: Astonea Labs Ltd announced the incorporation of a proposed subsidiary, Longevity Science…
Read the full analysis - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Company Updatelow impact
Cruxal's analysis: Please find enclosed herewith the Certificate under Reg. 74(5) of the SEBI (Depositories…
Read the full analysis - Intimation for Closure of Trading Window.Insider Trading / SASTlow impact
- Astonea Labs Limited Rectifies Regulatory Filing Omission for Half Year Ended March 2025Resultlow impact
Cruxal's analysis: Astonea Labs Limited has submitted the missing PDF version of its standalone financial…
Read the full analysis - Astonea Labs Limited Submits Clarification and Rectification of Financial Disclosures for FY2025Resultlow impact
Cruxal's analysis: Astonea Labs Limited has submitted a formal clarification and rectification to the BSE…
Read the full analysis - Astonea Labs Limited: Promoter Ashish Gulati Increases Stake via Open Market AcquisitionInsider Trading / SASTlow impact
Cruxal's analysis: Astonea Labs Limited has disclosed that promoter Ashish Gulati acquired 14,000 equity…
Read the full analysis - Astonea Labs Ltd: Promoter Ashish Gulati submits Regulation 7(2) insider trading disclosureCompany Updatelow impact
Cruxal's analysis: Astonea Labs Ltd has filed a disclosure under Regulation 7(2) of the SEBI (Prohibition of…
Read the full analysis - Astonea Labs Limited: Promoter Ashish Gulati Increases Stake via Open Market AcquisitionCompany Updatemedium impact
Cruxal's analysis: Astonea Labs Limited has disclosed that promoter Ashish Gulati acquired 14,000 equity…
Read the full analysis - Astonea Labs Limited appoints Mr. Chander Shekhar as Internal Auditor for FY 2026-27Company Updatelow impact
Cruxal's analysis: Astonea Labs Limited has formally announced the appointment of Mr. Chander Shekhar of…
Read the full analysis - Astonea Labs Limited Announces Strategic Subsidiary Incorporation, US Capital Infusion, and Termination of Key AgreementsOthersmedium impact
Cruxal's analysis: Astonea Labs Limited has approved the incorporation of a new subsidiary, 'Longevity…
Read the full analysis - Astonea Labs Ltd receives approval for alteration of Memorandum of Association object clauseCompany Updatelow impact
Cruxal's analysis: Astonea Labs Ltd has formally approved the alteration of the Object Clause in its…
Read the full analysis - Astonea Labs Limited announces re-appointment of Ms. Pooja Singh as DirectorCompany Updatelow impact
Cruxal's analysis: Astonea Labs Limited has formally announced the re-appointment of Ms. Pooja Singh as a…
Read the full analysis - Astonea Labs Limited Receives Shareholder Approval for Strategic Expansion and Subsidiary IncorporationAGM/EGMmedium impact
Cruxal's analysis: Astonea Labs Limited has successfully concluded its 9th Annual General Meeting, securing…
Read the full analysis - Astonea Labs Limited concludes 9th AGM; reports FY 2025-26 revenue of INR 148 crore and PAT of INR 4.51 croreAGM/EGMmedium impact
Cruxal's analysis: Astonea Labs Limited successfully held its 9th Annual General Meeting, marking its first…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.